|
|
||||||||
Original Research Communication |
1 From the Department of International Health, Rollins School of Public Health (UR and ADS) and the Doctoral Program in Nutrition and Health Sciences, Graduate Division of Biological and Biomedical Sciences (EK), Emory University, Atlanta.
Background: The increasing proportion of iron-replete individuals in industrialized countries and the possible increased risk of cardiovascular disease (CVD) among men with high iron stores raise concerns regarding improved iron status in women of reproductive age.
Objective: This study examined the association between iron stores and a set of established CVD risk factors among nonpregnant women aged 2049 y.
Design: Data from the third National Health and Nutrition Examination Survey (19881994) were used to examine the relation between race-ethnicityspecific quartiles of serum ferritin (SF) and a set of CVD risk factors [body mass index (BMI), total cholesterol, triacylglycerol, HDL cholesterol, plasma glucose, and blood pressure (BP)]. Women with a history of CVD or liver disease were excluded. We controlled for age, session of measurement, prevalent infection, recent blood donation, and treatment with iron for anemia.
Results: Mean SF values were 53.22 ± 2.08 µg/L (n = 1178), 58.93 ± 2.39 µg/L (n = 1093), and 43.33 ± 1.39 µg/L (n = 1075) among non-Hispanic white, non-Hispanic black, and Mexican American women, respectively. Iron stores were positively associated with CVD risk factors only among non-Hispanic black and Mexican American women after adjustment for confounding variables. The strongest associations were seen among Mexican American women: compared with the middle 2 quartiles, the lowest and highest quartiles of SF had lower and higher values, respectively, for BMI, total cholesterol, triacylglycerol, glucose, and diastolic BP.
Conclusion: These findings suggest that CVD risk factors, especially those related to glucose and lipid metabolism, are positively associated with iron status in women.
Key Words: Cardiovascular disease heart disease women premenopausal women iron stores iron status anemia ferritin blood lipids lipid metabolism glucose metabolism NHANES III
This article has been cited by other articles:
![]() |
S. Swaminathan, V. A. Fonseca, M. G. Alam, and S. V. Shah The Role of Iron in Diabetes and Its Complications Diabetes Care, July 1, 2007; 30(7): 1926 - 1933. [Full Text] [PDF] |
||||
![]() |
L. R. Zacharski, B. K. Chow, P. S. Howes, G. Shamayeva, J. A. Baron, R. L. Dalman, D. J. Malenka, C. K. Ozaki, and P. W. Lavori Reduction of Iron Stores and Cardiovascular Outcomes in Patients With Peripheral Arterial Disease: A Randomized Controlled Trial JAMA, February 14, 2007; 297(6): 603 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rajpathak, J. Ma, J. Manson, W. C. Willett, and F. B. Hu Iron Intake and the Risk of Type 2 Diabetes in Women: A prospective cohort study. Diabetes Care, June 1, 2006; 29(6): 1370 - 1376. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, T. O. Scholl, and T. P. Stein Association of Elevated Serum Ferritin Levels and the Risk of Gestational Diabetes Mellitus in Pregnant Women: The Camden Study Diabetes Care, May 1, 2006; 29(5): 1077 - 1082. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |